Clinical Trial

Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients

Study acronym: PATREAL
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2026 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This registry will provide exploratory and descriptive information regarding contemporary practice patterns of parenteral antiplatelet therapy in the PCI (Percutaneous Coronary Intervention) setting and will investigate as well the short-term effectiveness and safety of the currently available parenteral antiplatelet agents in a cohort of "real-world" patients undergoing PCI in Spain.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2021-12-31; most recent amendment 2026-02-09.
Status change: Recruiting → Active, Not Recruiting 2026-02-09
Status change: Not Yet Recruiting → Recruiting 2022-03-23
Trial Details
NCT Number NCT05193019
Lead Sponsor Fundación EPIC
Conditions Ischemic Heart Disease, Acute Coronary Syndrome
Enrollment 717 participants
Start Date 2022-03-14
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-10